Addiction & agency
Is there a disease-like stage in addiction?
Open access · cc by · source: Europe PMC
Snoek argues Lewis is right that BDMA’s ‘chronic brain disease’ slogan does not follow from the mechanisms, and she models a temporary duress-like stage that recovery can pass through.
Study at a glance
- Design
- Other — Philosophical reply to Lewis distinguishing BDMA mechanisms from the chronic-disease slogan
- N
- Conceptual analysis; not an empirical sample
- Population
- BDMA mechanisms, norms, and recovery/self-efficacy discourse about addiction
- Outcome
- Temporary duress-like addiction stage compatible with recovery without chronic-disease branding
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
Some addictions have a duress-like stage: self-control is hard, agency is only temporarily compromised, and it can be overcome stepwise after several attempts. Calling the whole course a disease can undermine belief in self-efficacy.
Methodology
She analyses BDMA as three parts: technical mechanisms, normative translation (chronic disease), and social goals (destigmatise, treat). Lewis mostly accepts the mechanisms and rejects the normative leap. She discusses self-efficacy, the merits and risks of Lewis’s model, and diachronic versus synchronic self-control.
Limitations
Empirical remarks draw on a prior ARC study, not a new trial. Ego-depletion is flagged as controversial. It does not map every client onto the duress stage.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Authors split on whether there is a temporary disease-like or duress-like stage: Snoek models one that recovery can pass through, while Heather and Lewis reject chronic-disease framing more flatly.
Evidence for the claim as stated.
The method has been used to test the political claims of the brain disease model of addiction (BDMA) against what is known about stigma and public understanding. Heather concludes that the claim that only a brain-disease story can fight stigma is false and that addiction is neither brain disease nor moral failing; Snoek separates the model's technical mechanisms from its normative translation into 'chronic disease' and argues that the label can undermine belief in self-efficacy.
Evidence for the claim as stated.
In practice the empirical base is often small and borrowed, and is used to illustrate rather than to prove. The narrative-devices paper draws on a DBS interview literature in which two of six participants reported a changing sense of self; Snoek's empirical remarks come from a prior ARC study; Mehling and colleagues interview leading practitioners rather than running a trial.
Evidence for the claim as stated.
A recurring move is to separate a mechanism from what the mechanism is taken to justify. Snoek's three-part analysis keeps the BDMA's mechanisms while rejecting the leap to chronic disease; the consciousness paper stresses that indicators are not the same as a metaphysical definition; the Dubos study shows a similar pattern in history of science, where virulence turned out not to be a property of microbes alone once host physiology and environment were considered.
Evidence for the claim as stated.
How much of the brain disease model to keep. Heather rejects it wholesale, calling its eliminative reductionism inhumane and unintelligent and fearing more medicalisation and pharma collaboration; Snoek, following Lewis, accepts most of the mechanisms and keeps a temporary, duress-like disease stage that recovery can pass through. Both engage the same stigma and self-efficacy considerations but land in different places.
Evidence for the claim as stated.
A single theorist's position can serve as the case. Snoek uses Lewis's critique of the brain disease model as a springboard to decompose that model into technical mechanisms, normative translation and social goals, and then models a temporary duress-like stage of addiction, with empirical remarks drawn from a prior ARC study rather than new data.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
Authors split on whether there is a temporary disease-like or duress-like stage: Snoek models one that recovery can pass through, while Heather and Lewis reject chronic-disease framing more flatly.
- Supports · Must addiction be disease or vice?
- Supports · Is addiction a brain disease or development?
How much of the brain disease model to keep. Heather rejects it wholesale, calling its eliminative reductionism inhumane and unintelligent and fearing more medicalisation and pharma collaboration; Snoek, following Lewis, accepts most of the mechanisms and keeps a temporary, duress-like disease stage that recovery can pass through. Both engage the same stigma and self-efficacy considerations but land in different places.
- Supports · Must addiction be disease or vice?
Related papers in this topic
Same topic cluster — not a recommendation engine.